Collegium Pharmaceutical, Inc.
COLL
$47.85
$0.340.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 58.44M | 36.27M | 43.89M | 69.19M | 88.59M |
| Total Depreciation and Amortization | 226.19M | 211.43M | 190.29M | 169.16M | 148.11M |
| Total Amortization of Deferred Charges | 5.49M | 5.35M | 5.60M | 6.02M | 6.56M |
| Total Other Non-Cash Items | 14.06M | 19.14M | 23.72M | 15.59M | 24.30M |
| Change in Net Operating Assets | -13.26M | -68.71M | -65.07M | -54.98M | -73.89M |
| Cash from Operations | 290.92M | 203.48M | 198.44M | 204.98M | 193.67M |
| Capital Expenditure | -1.62M | -1.68M | -1.88M | -1.65M | -1.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -267.54M | -267.54M | -267.54M | -267.54M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.60M | -4.11M | -9.89M | -18.57M | -32.31M |
| Cash from Investing | -55.23M | -273.32M | -279.31M | -287.76M | -301.09M |
| Total Debt Issued | 11.83M | 325.00M | 325.00M | 325.00M | 319.46M |
| Total Debt Repaid | -64.58M | -213.06M | -275.97M | -305.66M | -335.34M |
| Issuance of Common Stock | 4.83M | 3.16M | 8.57M | 11.07M | 14.14M |
| Repurchase of Common Stock | -62.39M | -61.57M | -76.91M | -79.20M | -79.12M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.38M | -19.38M | -12.38M | -11.83M | -6.28M |
| Cash from Financing | -129.70M | 34.15M | -31.69M | -60.60M | -87.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.99M | -35.69M | -112.56M | -143.38M | -194.57M |